novel weapons FALLUJAH - Cancer, Infant Mortality and Birth Sex-Ratio in Fallujah, Iraq 2005–2009
Dr. Chris Busby, a world famous UK based physicist, was at the UN last week with the results of his health survey comparing the health of the city of Fallujah, Iraq with 38 Hiroshimas.
The results were truly astonishing, even to the jaded eyes of UN representatives, old retired war fighters and politically connected bureaucrats. No armed force had accomplished this level of death and disease in a civilian population before.
There it was in black and white, on paper, from an internationally respected physicist – the utterly unbelievable, but certified results: Fallujah's leukemia rate was 38 times higher than Hiroshima after the US Atomic Bombing in 1945. The questions were fast and furious.
- How did the US do that? and,
- What weapons did the US deploy on the civilian population to cause so much cancer? and,
- Did the US nuke weapons labs develop a Cancer Bomb?
The Livermore Nuclear Weapons Lab in California and the Lethality Center at Picatinney Aresenal in New Jersey were most certainly involved
"A documentary on Italian television on Tuesday accuses American forces of using white phosphorus shells in the assault on Fallujah last year not just for nighttime illumination, their usual purpose, but to burn to death Iraqi insurgents and civilians. The mainstream American news media, whose reporters had witnessed the fighting and apparently seen no evidence of this, largely ignored the claim."
"They used these weird bombs that put up smoke like a mushroom cloud," Abu Sabah, another Fallujah refugee from the Julan area told IPS. "Then small pieces fall from the air with long tails of smoke behind them."
Dr. Chris Busby
Abstract: There have been anecdotal reports of increases in birth defects and cancer in Fallujah, Iraq blamed on the use of novel weapons (possibly including depleted uranium) in heavy fighting which occurred in that town between US led forces and local elements in 2004. In Jan/Feb 2010 the authors organised a team of researchers who visited 711 houses in Fallujah, Iraq and obtained responses to a questionnaire in Arabic on cancer, birth defects and infant mortality. The total population in the resulting sample was 4,843 persons with and overall response rate was better than 60%. Relative Risks for cancer were age-standardised and compared to rates in the Middle East Cancer Registry (MECC, Garbiah Egypt) for 1999 and rates in Jordan 1996–2001. Between Jan 2005 and the survey end date there were 62 cases of cancer malignancy reported (RR = 4.22; CI: 2.8, 6.6; p < 0.00000001) including 16 cases of childhood cancer 0-14 (RR = 12.6; CI: 4.9, 32; p < 0.00000001). Highest risks were found in all-leukaemia in the age groups 0-34 (20 cases RR = 38.5; CI: 19.2, 77; p < 0.00000001), all lymphoma 0–34 (8 cases, RR = 9.24;CI: 4.12, 20.8; p < 0.00000001), female breast cancer 0–44 (12 cases RR = 9.7;CI: 3.6, 25.6; p < 0.00000001) and brain tumours all ages (4 cases, RR = 7.4;CI: 2.4, 23.1; P < 0.004). Infant mortality was based on the mean birth rate over the 4 year period 2006–2009 with 1/6th added for cases reported in January and February 2010. There were 34 deaths in the age group 0–1 in this period giving a rate of 80 deaths per 1,000 births. This may be compared with a rate of 19.8 in Egypt (RR = 4.2 p < 0.00001) 17 in Jordan in 2008 and 9.7 in Kuwait in 2008. The mean birth sex-ratio in the recent 5-year cohort was anomalous.
Normally the sex ratio in human populations is a constant with 1,050 boys born to 1,000 girls. This is disturbed if there is a genetic damage stress. The ratio of boys to 1,000 girls in the 0–4, 5–9, 10–14 and 15–19 age cohorts in the Fallujah sample were 860, 1,182, 1,108 and 1,010 respectively suggesting genetic damage to the 0–4 group (p < 0.01). Whilst the results seem to qualitatively support the existence of serious mutation-related health effects in Fallujah, owing to the structural problems associated with surveys of this kind, care should be exercised in interpreting the findings quantitatively.